Tambalihol, Eduardo A.
HRN: 21-81-92 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/15/2024
CEFTAZIDIME 1GM (VIAL)
05/15/2024
05/21/2024
IV
1g
Q8
CAP-MR; T/c PTB Relapse
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes